Close Menu

Missing From Trials

African-American patients are missing out on cancer drug clinical trial opportunities, Stat News and ProPublica report. Their analysis of US Food and Drug Administration data found that for most trials for cancer drugs approved since 2015, fewer than 5 percent of the patients who participated were African American, even as African Americans make up 13.4 percent of the US population.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.

A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.